Sanofi Pasteur MSD GmbH Sustainability Profile
Sanofi Pasteur MSD GmbH, a prominent player in the biopharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 1994, the company has established itself as a leader in the development and distribution of vaccines, focusing on innovative solutions to prevent infectious diseases. With a diverse portfolio that includes vaccines for influenza, meningitis, and HPV, Sanofi Pasteur MSD is renowned for its commitment to public health and safety. The company’s unique approach combines cutting-edge research with a strong emphasis on quality, ensuring that their products meet the highest standards. Recognised for its significant contributions to vaccination programmes, Sanofi Pasteur MSD GmbH continues to strengthen its market position through strategic partnerships and a dedication to advancing immunisation efforts across the continent.
DitchCarbon Score
How does Sanofi Pasteur MSD GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sanofi Pasteur MSD GmbH's score of 69 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sanofi Pasteur MSD GmbH, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year. The company is a current subsidiary of Merck & Co., Inc., which influences its climate commitments and initiatives. While there are no documented reduction targets or specific emissions figures available, Sanofi Pasteur MSD GmbH's climate strategy is aligned with the broader initiatives of its parent company, Merck & Co., Inc. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which aim to enhance transparency and accountability in corporate climate action. As a subsidiary, Sanofi Pasteur MSD GmbH benefits from the sustainability frameworks and targets set by Merck & Co., Inc., which are cascaded down through the corporate structure. This relationship underscores the importance of collaborative efforts in addressing climate change within the pharmaceutical industry. In summary, while specific emissions data and reduction targets for Sanofi Pasteur MSD GmbH are not available, the company is positioned within a corporate family that prioritises climate action and sustainability through established initiatives from its parent organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,532,400,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 5,760,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Sanofi Pasteur MSD GmbH's Industry?
How Carbon Intensive is Sanofi Pasteur MSD GmbH's Location?
Sanofi Pasteur MSD GmbH's Scope 3 Categories Breakdown
Sanofi Pasteur MSD GmbH's Scope 3 emissions, which increased by 3% last year and increased by approximately 5% since 2014, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.
Top Scope 3 Categories
Sanofi Pasteur MSD GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sanofi Pasteur MSD GmbH has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.